You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

apx005m

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Houston (APX005M, Pembrolizumab)

Recruiting
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Ovarian Cancer Trial in Copenhagen (APX005M)

Not yet recruiting
  • Ovarian Cancer
  • APX005M
  • Copenhagen, Sjaelland, Denmark
    NSGO-CTU
Apr 19, 2022

Soft Tissue Sarcoma Trial in New York (Doxorubicin, APX005M)

Recruiting
  • Soft Tissue Sarcoma
  • New York, New York
    Columbia University Medical Center
Nov 12, 2021

Unresectable Melanoma, Metastatic Melanoma Trial in Poland, Spain (APX005M)

Active, not recruiting
  • Unresectable Melanoma
  • Metastatic Melanoma
  • APX005M
  • Warsaw, Poland
  • +12 more
Mar 8, 2022

Advanced Melanoma, Renal Cell Carcinoma Trial in New Haven (Nivolumab, Ipilimumab, APX005M)

Recruiting
  • Advanced Melanoma
  • Renal Cell Carcinoma
  • New Haven, Connecticut
  • +1 more
Nov 2, 2021

Cancer, Non Small Cell Lung Cancer Metastatic, Metastatic Melanoma Trial in Spain, United States (APX005M, Nivolumab)

Completed
  • Cancer
  • +4 more
  • Tucson, Arizona
  • +22 more
Dec 3, 2021

Cancer, NSCLC, Melanoma Trial in Duarte, Cleveland, Philadelphia (APX005M)

Completed
  • Cancer
  • +5 more
  • APX005M
  • Duarte, California
  • +2 more
Apr 27, 2020